The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(1H-Indazol-5-yl)-N-[(1-methylpyrazol-3-yl)methyl]-4-(2-pyridyl)thiazol-2-amine ID: ALA3822572
PubChem CID: 127048931
Max Phase: Preclinical
Molecular Formula: C20H17N7S
Molecular Weight: 387.47
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cn1ccc(CN(c2ccc3[nH]ncc3c2)c2nc(-c3ccccn3)cs2)n1
Standard InChI: InChI=1S/C20H17N7S/c1-26-9-7-15(25-26)12-27(16-5-6-17-14(10-16)11-22-24-17)20-23-19(13-28-20)18-4-2-3-8-21-18/h2-11,13H,12H2,1H3,(H,22,24)
Standard InChI Key: DDEMFZYBCBJLRK-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 32 0 0 0 0 0 0 0 0999 V2000
-6.5081 -1.0769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0429 -0.7557 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-4.9145 0.7260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2698 1.3384 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-7.2664 0.2173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6211 1.4874 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.6329 2.9882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.7599 0.3646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.4766 1.6766 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.9763 1.7111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-11.7559 0.4297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-11.0360 -0.8863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.5364 -0.9208 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.3395 3.7496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2111 5.2313 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.7459 5.5525 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0124 4.2583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9842 3.1372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2649 6.6519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 1 2 0
3 6 1 0
6 7 1 0
6 8 1 0
5 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
8 15 2 0
15 19 1 0
18 16 1 0
16 17 2 0
17 8 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 18 1 0
7 23 1 0
23 24 2 0
24 25 1 0
25 26 1 0
26 27 2 0
27 23 1 0
25 28 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 387.47Molecular Weight (Monoisotopic): 387.1266AlogP: 4.15#Rotatable Bonds: 5Polar Surface Area: 75.52Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.98CX Basic pKa: 2.25CX LogP: 3.74CX LogD: 3.74Aromatic Rings: 5Heavy Atoms: 28QED Weighted: 0.49Np Likeness Score: -2.21
References 1. Gardinier KM, Gernert DL, Porter WJ, Reel JK, Ornstein PL, Spinazze P, Stevens FC, Hahn P, Hollinshead SP, Mayhugh D, Schkeryantz J, Khilevich A, De Frutos O, Gleason SD, Kato AS, Luffer-Atlas D, Desai PV, Swanson S, Burris KD, Ding C, Heinz BA, Need AB, Barth VN, Stephenson GA, Diseroad BA, Woods TA, Yu H, Bredt D, Witkin JM.. (2016) Discovery of the First α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Antagonist Dependent upon Transmembrane AMPA Receptor Regulatory Protein (TARP) γ-8., 59 (10): [PMID:27067148 ] [10.1021/acs.jmedchem.6b00125 ]